The Substance Abuse and Mental Health Services Administration (SAMHSA), is seeking public comments on the Federal Guidelines for Opioid Treatment. SAMHSA published this preliminary set of guidelines to provide more detailed information to opioid treatment programs (OTP), and organizations that accredidate them, about what they need to comply with new requirements under the Code of Federal Regulations (42 CFR Part 8).
As part of its effort to finalize the guidelines, SAMHSA is asking representatives from OTPs, accreditation organizations, patients groups, the medical community and other interested members of the public to review and comment on these preliminary guidelines. The guidelines are available at: http://www.dpt.samhsa.gov/pdf/FederalGuidelinesforOpioidTreatment5-6-2013revisiondraft_508.pdf
. All comments submitted by the deadline of July 16, 2013 will be carefully considered.
Electronic comments can be sent to: DPT@samhsa.hhs.gov
. Written comments should be mailed to the following address ONLY:
Substance Abuse and Mental Health Services Administration
Attention: DPT Federal Register Representative, Division of Pharmacologic Therapies
1 Choke Cherry Road, Room 7-1044
Rockville, MD 20857.
Please allow sufficient time for mailed comments to be received before the close of the comment period.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the agency within the U.S. Department of Health and Human Services that leads public health efforts to advance the behavioral health of the nation. SAMHSA's mission is to reduce the impact of substance abuse and mental illness on America's communities.